Revolutionizing the treatment of memory loss
We’re passionate about improving the quality of life for our aging population.
Who are we ?
Casp-Aid Inc. is a biotechnology startup company based in Montreal. We are driven to revolutionize the treatment of memory loss in aging populations through a novel approach based on over 30 years of research.
We are committed to finding a treatment that not only prevents or delays memory impairment but normalizes memory function.
COGNITIVE IMPAIRMENT AFFECTS MANY INDIVIDUALS
10-15% convert to dementia yearly.
Affects non-Alzheimer individuals.
First symptom of Alzheimer desease.
Negative social, economic, financial impact.